|
Anapafseos 5 Agios Nikolaos 72100,Crete,Greece,00302841026182,00306932607174,alsfakia@gmail.com
Blog Archive
- ► 2022 (3010)
-
▼
2021
(9899)
-
▼
May
(923)
-
▼
May 10
(28)
- Salidroside overcomes dexamethasone resistance in ...
- Changes in peri-ocular anatomy and physiology in p...
- Gallic acid suppresses colon cancer proliferation ...
- Protein kinase N1 promotes proliferation and invas...
- Interleukin-1 induces receptor activator of nuclea...
- miR-221-3p and miR-222-3p regulate the SOCS3/STAT3...
- Life-threatening complications of hyperemesis grav...
- Anticancer activity of bergenin against cervical c...
- Upregulation of long non-coding RNA MYU promotes p...
- Apatinib inhibits gastric carcinoma development by...
- Hypoxia-inducible factor-1α regulates PI3K/AKT sig...
- Effect of Porphyromonas gingivalis lipopolysacchar...
- Differential proteomic analysis of tibial subchond...
- Regulatory mechanism of calcium/calmodulin-depende...
- Influence of fine particulate matter and its pure ...
- Association of obstructive sleep apnea/hypopnea sy...
- Clinical and diagnostic value of the combination o...
- Facing coronavirus disease 2019: What do we know s...
- lncRNA NORAD promotes the progression of osteosarc...
- MicroRNA-219a-2-3p modulates the proliferation of ...
- Microarray analysis of the time-dependent expressi...
- Transcriptomic analysis and competing endogenous R...
- Diagnostic accuracy of ultrasonography for the pre...
- Apoptosis in HUVECs induced by microRNA-616-3p via...
- Effects of leukocyte- and platelet-rich plasma on ...
- Effects of hypothermia on inflammatory cytokine ex...
- Effects of Supine and Prone Positions on Nasal Pat...
- Role of Bilateral Inferior Turbinoplasty as an Adj...
-
▼
May 10
(28)
-
▼
May
(923)
- ► 2020 (4138)
- ► 2019 (2429)
Αλέξανδρος Γ. Σφακιανάκης
Monday, May 10, 2021
Anticancer activity of bergenin against cervical cancer cells involves apoptosis, cell cycle arrest, inhibition of cell migration and the STAT3 signalling pathway
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment